Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
Encoded Therapeutics has raised $275.0M in total funding. The most recent round was Series F. The last funding was announced in September 2026.
Encoded Therapeutics's investors include Menlo Ventures, ARCH Venture Partners, Venrock, Janus Henderson Investors, Invus.
Encoded Therapeutics is headquartered in South San Francisco, United States.
Encoded Therapeutics is a biotechnology company developing genetic medicines for neurological disorders and other diseases.
Encoded Therapeutics is at the Series F stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Encoded Therapeutics — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/encoded-therapeutics. Accessed November 6, 2026.
VCBacked. (2026). Encoded Therapeutics — Funding & Investors. Retrieved November 6, 2026, from https://www.vcbacked.co/company/encoded-therapeutics
{{cite web |title=Encoded Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/encoded-therapeutics |website=VCBacked |access-date=November 6, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Encoded Therapeutics? Request a listing update